6533b829fe1ef96bd128abb3
RESEARCH PRODUCT
Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin and chemo-radiation in stage III NSCLC. SLCG 10/02.
Pilar Mut SanchisVanesa Gutierrez CalderonNatividad Martinez BanaclochaAmelia InsaMaria Francisca VazquezRaquel Marse FabregatI. MaestuMaria Angeles Sala GonzalezBartomeu MassutiJosé Gómez-codinaAngel Artal-cortesAna Laura Ortega GranadosDolores IslaNuria ViñolasCarlos CampsMariano Provencio-pullaRamon De Las PenasTeresa MoranJosé Miguel JuradoPilar Dizsubject
OncologyCisplatinCancer Researchmedicine.medical_specialtybusiness.industryStage III NSCLCVinorelbineChemo radiationOncologyInternal medicineMedicinebusinessEtoposidemedicine.drugdescription
e20521Background: This study aims to compare efficacy and safety of two widely used combinations of cisplatin (P) in this setting: as etoposide (E) and vinorelbine. This last, in its oral formulati...
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-05-20 | Journal of Clinical Oncology |